Pharmaceutical formulation comprising gonadotropin-releasing hormone (GnRH), a GnRH agonist or antagonist of GnRH and method of Treatment

摘要

Claim 1: a Pharmaceutical formulation comprising a Solid Matrix of one or more biodegradable Polymers,The Solid Matrix which includes a pharmaceutically active substance or one of its Salts are acceptable from the point of view of pharmaceutical Distributed homogeneously or substantially homogeneous within the Matrix, where the pharmaceutically active substance Releasing Hormone Hormone (GnRH), a GnRH agonist or antagonist of GnRH.Claim 2: a Pharmaceutical formulation according to claim 1 in which the pharmaceutically active substance degarelix. Claim 7: a Pharmaceutical formulation according to claim 1 where (OR) is a biodegradable polymer of lactic acid Glycolic Acid Copolymer (PLGA).